PRGO Q2 2018 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B-4.2% YoY

Gross Profit

$471M39.7% margin

Operating Income

$95M8.0% margin

Net Income

$36M3.1% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

-2.5%

Cash Flow

Operating Cash Flow

$82M

Free Cash Flow

$62M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$11.2B

Total Liabilities

$5.3B

Stockholders' Equity

$5.9B

Cash & Equivalents

$527M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	-4.2%
Gross Profit	$471M	$505M	-6.7%
Operating Income	$95M	$149M	-36.4%
Net Income	$36M	-$70M	+152.0%

Revenue Segments

Consumer Self-Care Americas

$597M50%

Consumer Self-Care International

$381M32%

RX Pharmaceuticals

$209M18%

Geographic Segments

UNITED STATES

$772M65%

Europe

$344M29%

Other Geographical Areas

$70M6%

IRELAND

$5M0%